Fibroplate Inc.

Las Vegas, NV

UEI
UKBYP1UTHBK1
CAGE
6XDJ6
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Fibroplate Inc. is a corporate entity registered in SAM.gov since 2013, specializing in advanced biomedical research and development of innovative nanosphere technologies for medical applications. The company focuses on creating cutting-edge therapeutic interventions using fibrinogen-coated albumin nanospheres (FAS), which demonstrate potential for accelerating healing processes in various medical conditions. As a for-profit organization, Fibroplate Inc. has been actively engaged in developing biomedical solutions that address complex clinical challenges, particularly in areas of wound healing, bone regeneration, and platelet-related medical complications.

Through federal grant awards from civilian agencies like the National Cancer Institute, National Institute on Aging, and National Heart Lung and Blood Institute, Fibroplate Inc. has conducted targeted research on multiple medical innovations. Their Small Business Innovation Research (SBIR) Phase I projects have explored breakthrough treatments such as accelerating surgical wound healing for breast cancer patients undergoing radiation therapy, improving bone fracture healing in elderly populations, and developing interventions for patients with platelet transfusion refractoriness. Each project demonstrates a sophisticated approach to medical research, utilizing their proprietary Fibrinoplate-S (FPS) technology to address specific clinical challenges. The grants, ranging from approximately $386,470 to undisclosed amounts, support preclinical research aimed at developing potential therapeutic agents that could significantly improve patient outcomes in oncology, geriatric medicine, and hematology. By focusing on nanosphere technologies that promote cellular mobilization and counteract inflammatory states, Fibroplate Inc. is positioning itself as an innovative biomedical research organization with potential for transformative medical solutions.

Quick answers

Is Fibroplate Inc. registered in SAM.gov?

Yes. Fibroplate Inc.'s SAM.gov registration is active through August 22, 2027.

What is Fibroplate Inc.'s CAGE code?

Fibroplate Inc.'s CAGE code is 6XDJ6, and its Unique Entity ID (UEI) is UKBYP1UTHBK1.

What is Fibroplate Inc.'s most recent federal award?

Fibroplate Inc.'s most recent federal grant award is Fibrinogen-coated albumin spheres to accelerate bone healing in older adults (R44AG099306), from National Institute on Aging (NIH), on September 17, 2026.

On GovTribe

See Fibroplate Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe